Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guidelines – Squamous Cell Carcinoma of the Head and Neck

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Published in 2020 – Ann Oncol (2020)

Authors: J.-P. Machiels, CRené Leemans, W. Golusinski, C. Grau, L. Licitra, V. Gregoire, on behalf of the EHNS Executive Board, ESMO Guidelines Committee, ESTRO Head Office

  • This EHNS-ESMO-ESTRO Clinical Practice Guideline provides key recommendations for managing SCCHN
  • It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up
  • Opportunities for personalised medicine in SCCHN are also discussed
  • All recommendations were compiled by a multidisciplinary group of experts from different institutions and countries
  • Recommendations are based on available clinical evidence and the collective expert opinion of the authors

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.